Participants 59 88 4
adults with autistic disorder
Participants 496 532 7
Thirty adults with autistic disorder
Participants 764 823 4
Eight (53%) of 15 patients in the fluvoxamine-treated group
Participants 869 900 4
none of 15 in the placebo group
